Tech Company Financing Transactions
Amnis Funding Round
Medventure Associates, OrbiMed and private investors participated in a $830 thousand funding round for Amnis. The round was announced on 9/30/2009.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$830,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2505 Third Ave. 210
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Overview
Amnis Corporation has created the ImageStream Cell Analysis System, a breakthrough technology for high speed imaging and analysis of cells in flow. The system is a next generation instrument that combines the power of microscopy and flow cytometry in a single platform to advance applications in drug discovery, basic biomedical research and diagnostics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Basiji
Chief Financial Officer
Patrick McDermott
Chief Operating Officer
William Ortyn
VP - Engineering
David Perry
VP - Sales
Christopher Doman
Browse more venture capital transactions:
Prev: 9/30/2009: Brightkite venture capital transaction
Next: 9/30/2009: Reata Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs